Rituximab treatment of idiopathic membranous nephropathy-Reference-Cited by-同舟云学术

Rituximab treatment of idiopathic membranous nephropathy

Published:2008-01 Issue:1 Volume:73 Page:117-125
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Fervenza F.C.,Cosio F.G.,Erickson S.B.,Specks U.,Herzenberg A.M.,Dillon J.J.,Leung N.,Cohen I.M.,Wochos D.N.,Bergstralh E.,Hladunewich M.,Cattran D.C.

Publisher

Elsevier BV

Subject

Nephrology

Reference30 articles.

1. Membranous nephropathy: quo vadis? [comment];Cattran;Kidney Int,2002

2. Rituximab in idiopathic membranous nephropathy: a one-year prospective study;Ruggenenti;J Am Soc Nephrol,2003

3. Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis);Kerjaschki;J Am Soc Nephrol,1996

4. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy;Ponticelli;Kidney Int,1995

5. Suppression of human B lymphocyte function by cyclophosphamide;Cupps;J Immunol,1982

Cited by 224 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B cell dysregulation and depletion therapy in primary membranous nephropathy: Prospects and potential challenges;International Immunopharmacology;2024-10

2. Membranous Nephropathy: Updates on Management;Advances in Kidney Disease and Health;2024-07

3. Is There a Place for Apheresis in the Management of Idiopathic Membranous Nephropathy? A Report of Three Cases and Literature Review;Journal of Personalized Medicine;2024-02-26

4. Optimization of Rituximab Therapy in Adult Patients With PLA2R1-Associated Membranous Nephropathy With Artificial Intelligence;Kidney International Reports;2024-01

5. Anti-CD20 antibodies in glomerular diseases, their resistance and reversal approaches;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024